Search
for
Sort by
Research 301–330 of 725
- Relapse of Alopecia Areata Responders After Tofacitinib Withdrawal: A Retrospective Study of 59 Patients
- Machine Learning Guided Discovery of Superoxide Dismutase Nanozymes for Androgenetic Alopecia
- The Role of Patients in Alopecia Areata Endpoint Development: Understanding Physical Signs and Symptoms
- Treatment of chronic alopecia areata with tildrakizumab: an open‐label pilot study
- A summary of in vitro, phase I, and phase II studies evaluating the mechanism of action, safety, and efficacy of clascoterone (cortexolone 17a propionate, CB-03-01) in androgenetic alopecia
- Remarks on Perfection in Plastic Surgery of the Face
- Mapping penetration of cosmetic compounds into hair fibers using time‐of‐flight secondary ion mass spectrometry (TOF‐SIMS)
- Facial Framing: “It’s not all about the hair, it’s about the eyes”! Utilizing Art and Mathematic Principles in Facial Framing and Hair Restoration Design
- Pseudofolliculitis Barbae
- Undesirable effects of COVID-19 vaccination on Saudi population: A descriptive study, Winter 2022.
- 44096 Efficacy in Subgroups related to Disease Characteristics in Patients with Alopecia Areata from BRAVE-AA1 and BRAVE-AA2
- Reversal of premature hair graying treated with a topical formulation containing α-melanocyte-stimulating hormone agonist (Greyverse Solution 2%)
- Clinical features and treatment outcomes of frontal fibrosing alopecia in men
- Treatment of traction alopecia with oral minoxidil
- Finasteride in Frontal Fibrosing Alopecia: Joining the Dots!
- Mesotherapy with dutasteride and minoxidil in treatment of androgenetic alopecia
- Update on Efficacy of Generic Finasteride
- Notes from the Editor Emeritus: The empowered patient
- Psychological morbidity of hirsute women
- Low-dose oral minoxidil for pediatric and young-adult hair loss: a cross-sectional survey of satisfaction and perceived benefit
- Dupilumab's Bidirectional Effects on Alopecia Areata: A Systematic Review
- Dupilumab's Bidirectional Effects on Alopecia Areata: A Systematic Review
- The efficacy and safety of oral minoxidil greater than 5 mg daily in hair loss disorders: A systematic review
- The efficacy and safety of oral minoxidil greater than 5 mg daily in hair loss disorders: A systematic review
- No Increased Cardiovascular Hazard with Oral 5-Alpha-Reductase Inhibitors in Treatment of Androgenetic Alopecia: A TriNetX Retrospective Cohort Study
- Dyslipidemia and obstructive sleep apnea in men with androgenetic alopecia: an analysis from the EPISONO study
- Evaluation of Sexual Dysfunctions in Male Patients with Androgenetic Alopecia
- Baricitinib Provides Sustained, Long-Term Efficacy With Consistent Safety for Up to 5 Years of Treatment in Adults With Severe Alopecia Areata: Final Results From BRAVE-AA1 and BRAVE-AA2
- RETRACTION: The Causal Relationship between Androgenetic Alopecia and Serum Uric Acid: A Bidirectional Mendelian Randomization Analysis
- Educating for Empathy: Impact of a Targeted Alopecia Areata Curriculum on Middle School Students